Treatment for Chronic Fatigue Syndrome: What is Worth Doing?

Abstract: Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is a chronic limiting condition that effects around 0.3% of the population. Patients with CFS/ME frequently are unable to work and require support from families. There is a lack of consensus over the cause of CFS/ME and the most appropriate way of treating it. This presentation reports findings from the MRC/DWP-funded PACE study which was conducted in a number of UK centres and included 640 patients. The focus of the talk will be on the cost-effectiveness analyses which took account of health care use, informal care and lost work and used fatigue, disability and QALYs as outcomes.